Literature DB >> 10705813

Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases.

C A Moran1, S Suster.   

Abstract

We reviewed 11 cases of primary thymic neuroendocrine carcinomas with combined features ranging from well-differentiated to poorly differentiated neuroendocrine carcinoma. For 3 asymptomatic patients, tumors were discovered during routine examination. Presentation in the other patients was as follows: Cushing syndrome, 2 patients; chest pain, 3 patients; superior vena cava syndrome, 1 patient; and hypercalcemia and hypophosphatemia, 1 patient. No clinical data were available for the 11th patient. All tumors were located in the anterior mediastinum and treated by surgical excision. The lesions were large and well-circumscribed with areas of hemorrhage and necrosis. They were characterized by areas showing a proliferation of monotonous, round tumor cells adopting a prominent organoid pattern admixed with areas showing sheets of atypical cells with hyperchromatic nuclei, frequent mitoses, and extensive areas of hemorrhage and necrosis. Immunohistochemical studies performed in 6 cases showed strong CAM 5.2 low-molecular-weight cytokeratin positivity in all cases, chromogranin and synaptophysin positivity in 4, Leu-7 in 3, and focal positivity for p53 in 2. Follow-up information for 9 cases showed that all patients died of their tumors between 1 and 4 years after diagnosis. The present cases highlight the heterogeneity of neuroendocrine neoplasms and reinforce the notion that these tumors form part of a continuous spectrum of differentiation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705813     DOI: 10.1309/Q01U-60BL-VEV4-TWR1

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  13 in total

Review 1.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

Review 2.  Neuroendocrine tumors of the thymus and mediastinum.

Authors:  Hanibal Bohnenberger; Helen Dinter; Alexander König; Philipp Ströbel
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Pulmonary neuroendocrine carcinomas-evidence for a spectrum of differentiation.

Authors:  Annikka Weissferdt
Journal:  Virchows Arch       Date:  2018-01-31       Impact factor: 4.064

4.  Atypical thymoma (WHO B3) with neuroendocrine differentiation: report of a case.

Authors:  Junichi Shiraishi; Hiroaki Nomori; Hideki Orikasa; Taisuke Mori; Kazuto Yamazaki
Journal:  Virchows Arch       Date:  2006-05-04       Impact factor: 4.064

5.  A Case of Carcinoid Tumor-Associated Hypercalcemia.

Authors:  Fadi Siyam; Obai Abdullah; Michael Gardner; Stephen Brietzke; James Sowers
Journal:  Cardiorenal Med       Date:  2012-01-26       Impact factor: 2.041

6.  Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Paolo Bidoli; Stefania Canova; Diego Cortinovis; Maria Ida Abbate; Fiorella Calabrese; Nazarena Nannini; Francesca Lunardi; Giulio Rossi; Stefano La Rosa; Carlo Capella; Elena Tamborini; Federica Perrone; Adele Busico; Iolanda Capone; Barbara Valeri; Ugo Pastorino; Adriana Albini; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-04-27       Impact factor: 4.064

Review 7.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

8.  Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Authors:  Giuseppe Pelosi; Fabrizio Bianchi; Elisa Dama; Michele Simbolo; Andrea Mafficini; Angelica Sonzogni; Sara Pilotto; Sergio Harari; Mauro Papotti; Marco Volante; Gabriella Fontanini; Luca Mastracci; Adriana Albini; Emilio Bria; Fiorella Calabrese; Aldo Scarpa
Journal:  Virchows Arch       Date:  2018-02-01       Impact factor: 4.064

Review 9.  Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.

Authors:  Marco Volante; Luisella Righi; Sofia Asioli; Gianni Bussolati; Mauro Papotti
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

10.  Primary neuroendocrine tumors of the thymus: Clinical review of 22 cases.

Authors:  Zhengbo Song; Yiping Zhang
Journal:  Oncol Lett       Date:  2014-09-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.